USMF logo

Institutional Repository in Medical Sciences
of Nicolae Testemitanu State University of Medicine and Pharmacy
of the Republic of Moldova
(IRMS – Nicolae Testemitanu SUMPh)

Biblioteca Stiintifica Medicala
DSpace

University homepage  |  Library homepage

 
 
Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12710/1870
Full metadata record
DC FieldValueLanguage
dc.contributor.authorGladâş, Valentina
dc.contributor.authorCorcimaru, Ion
dc.contributor.authorRobu, Maria
dc.contributor.authorChelea, Iurii
dc.contributor.authorMusteaţă, Vasile
dc.contributor.authorMocanu, Irina
dc.date.accessioned2019-06-22T13:13:33Z-
dc.date.available2019-06-22T13:13:33Z-
dc.date.issued2011
dc.identifier.citationGLADAS, Valentina, CORCIMARU, Ion et al. Recidivele leucemiei acute promielocitare. In: Anale ştiinţifice ale USMF “Nicolae Testemiţanu”. Ed. a 12-a. Chişinau: СEP Medicina, 2011, vol. 3: Probleme actuale în medicina internă, pp. 347-351.en_US
dc.identifier.urihttp://repository.usmf.md/handle/20.500.12710/1870-
dc.descriptionCatedra Hematologie şi Oncologie a USMF “N.Testemiţanu” Instituţie Medico-Sanitară Publică Institutul de Oncologie din Moldovaen_US
dc.description.abstractWe have followed up 67 patients with acute promyelocytic leukemia, who underwent combined treatment with ATRA and polychemotherapy (PCT). Complete remissions were achieved in 55 (82,1%) cases. Early relapses were registered in 9 (34,6%) patients. Late relapses developed in 17 ( 66.4%) cases, four of these patients abolished the treatment. Relapses more often (82,4%) develop in the patients in first 3 years of complete remision, but in following years the frecvency of relapses is significantly reduced.Repeated combined treatment with ATRA and PCT appeared to be efficient in 5 (23,8%) cases. Key words: Acute promyelocytic leukemia, All-trans-retinoic acid, relapse. Sub supraveghere s-au aflat 67 de bolnavi de leucemie acută promielocitară, care au primit tratament cu ATRA în combinaţie cu polichimioterapie. Remisiuni complete au fost obţinute la 55 (82,1%) bolnavi. Recidive precoce au fost constatate la 9 (34,6%) pacienţi, recidive tardive în 17 (66,4%) cazuri. Recidivele mai frecvent (82,4%) au aparut în primii 3 ani de remisiune completă, ulterior cu scăderea lor considerabilă. Remisiune completă în tratamentul recidivelor a fost obţinută la 5 (23,8%) bolnavi.en_US
dc.language.isoroen_US
dc.publisherCEP Medicinaen_US
dc.subject.meshAcute Promyelocytic Leukaemiaen_US
dc.subject.meshTretinoinen_US
dc.subject.meshRecurrenceen_US
dc.titleRecidivele leucemiei acute promielocitareen_US
dc.title.alternativeRelapses of acute promyelocitic leukemiaen_US
dc.typeArticleen_US
Appears in Collections:Hematologie

Files in This Item:
File Description SizeFormat 
RECIDIVELE_LEUCEMIEI_ACUTE_PROMIELOCITARE.pdf134.09 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

 

Valid XHTML 1.0! DSpace Software Copyright © 2002-2013  Duraspace - Feedback